A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2011
11/03/2011	WO2011137418A1 Selective integrin inhibitors
11/03/2011	WO2011137109A1 Azaindazole amide compounds as ccr1 receptor antagonists
11/03/2011	WO2011136723A1 Polymorphs of a metabotropic glutamate receptor positive allosteric modulator
11/03/2011	WO2011136378A1 Grafting material for genetic and cell therapy
11/03/2011	WO2011136369A1 Cationic lipid
11/03/2011	WO2011136368A1 Cationic lipid
11/03/2011	WO2011136313A1 High-purity soluble thrombomodulin and method for producing same
11/03/2011	WO2011136308A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
11/03/2011	WO2011136247A1 Novel heteroaryl monocyclic pyrimidine derivative
11/03/2011	WO2011135351A1 Naphthridine derivatives as pi3k inhibitors for the treatment of cancer and immune - inflammatory diseases
11/03/2011	WO2011134831A1 Pyrazole compounds as jak inhibitors
11/03/2011	WO2011134271A1 Use of kukoamine a and kukoamine b
11/03/2011	WO2011134140A1 Pyrimidinyl indole compounds
11/03/2011	WO2011082290A3 Formulations from natural products, turmeric, and aspirin
11/03/2011	WO2011082175A3 Glycosaminoglycan inhibitors
11/03/2011	WO2011066378A3 Antagonists of il-6 to prevent or treat thrombosis
11/03/2011	WO2011065791A3 Metabolism accelerating composition comprising astragali radix extract
11/03/2011	WO2011060440A3 Kinase inhibitors
11/03/2011	WO2011056033A3 Pharmaceutical composition for preventing / treating trpv1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient
11/03/2011	WO2011053090A3 Novel 2, 4-pyrimidine derivatives and use thereof
11/03/2011	WO2010116282A8 4, 5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
11/03/2011	US20110271358 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
11/03/2011	US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011	US20110269947 Apo-2 ligand/trail formulations
11/03/2011	US20110269843 Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
11/03/2011	US20110269842 Compositions comprising cb receptor agonists, uses thereof and methods for their preparation
11/03/2011	US20110269839 Anti-snoring composition containing a termogelling polymer
11/03/2011	US20110269822 RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions
11/03/2011	US20110269811 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
11/03/2011	US20110269800 P38 map kinase inhibitors
11/03/2011	US20110269796 Use of Levocabastine for Modulating Generation of Pro-Inflammatory Cytokines
11/03/2011	US20110269794 External Preparation for Athlete's Foot Treatment
11/03/2011	US20110269788 Spiro-oxindole-derivatives as sodium channel blockers
11/03/2011	US20110269784 Use of tetrahydropyrimidines
11/03/2011	US20110269780 Aza-benzimidazolone chymase inhibitors
11/03/2011	US20110269773 Dihydrofuro pyrimidines as akt protein kinase inhibitors
11/03/2011	US20110269769 Imidazole derivatives useful as inhibitors of faah
11/03/2011	US20110269763 CRTH2 receptor ligands for medicinal uses
11/03/2011	US20110269760 Tubulin inhibitors
11/03/2011	US20110269759 Pyrimidine compounds as delta opioid receptor modulators
11/03/2011	US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/03/2011	US20110269753 Heterocyclic compounds as phosphodiesterase inhibitors
11/03/2011	US20110269749 Tricyclic carbamate jak inhibitors
11/03/2011	US20110269742 Serotonin 5-HT2B Receptor Inhibitors
11/03/2011	US20110269740 Jak kinase modulating compounds and methods of use thereof
11/03/2011	US20110269738 Compounds
11/03/2011	US20110269733 Silent Desensitizers of Neuronal nAChR and Methods of Use Thereof
11/03/2011	US20110269730 Metal Complexes of Thiourea and Derivatives as Metal Delivering Anti-Cancer and Anti-Inflammatory Agents
11/03/2011	US20110269727 Composition to reduce allodynic back pain and related method of use
11/03/2011	US20110269724 Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric Injuries
11/03/2011	US20110269704 Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically
11/03/2011	US20110269686 Cxcr4 antagonist and use thereof
11/03/2011	US20110269668 Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/03/2011	US20110268970 Mesoporous nanoparticles
11/03/2011	US20110268825 Compositions that include anthocyanidins and methods of use
11/03/2011	US20110268819 Antinfective free intramammary veterinary composition
11/03/2011	US20110268787 Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof
11/03/2011	US20110268784 Clay-based hemostatic agents and devices for the delivery thereof
11/03/2011	US20110268781 Drug eluting composite
11/03/2011	US20110268775 Nanoparticle pharmaceutical formulations
11/03/2011	US20110268771 Chewable gelled emulsions
11/03/2011	US20110268755 Survivin Peptides For Autoimmune Therapies
11/03/2011	US20110268743 PROBIOTICS, SECRETORY IgA AND INFLAMMATION
11/03/2011	US20110268730 Method for inhibiting bone resorption
11/03/2011	US20110268726 Anti-CD38 human antibodies and uses thereof
11/03/2011	US20110268725 Anti-NGF antibodies for the treatment of various disorders
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268719 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use
11/03/2011	US20110268715 Anti-inflammatory and anti-vaginitis food composition and pharmaceutical composition containing lactobacillus
11/03/2011	US20110268695 Use of hmgb fragments as anti-inflammatory agents
11/03/2011	US20110268694 Methods for treating vascular leak syndrome
11/03/2011	US20110268679 Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
11/03/2011	US20110268678 Vitamin d forming sunscreen
11/03/2011	US20110268677 Silicone Paste Compositions
11/03/2011	US20110268669 Composition and method for treating eustachian tube dysfunction
11/03/2011	US20110268665 Oil-based foamable carriers and formulations
11/03/2011	US20110268659 High shear application in drug delivery
11/03/2011	US20110268658 Polymer-agent conjugates, particles, compositions, and related methods of use
11/03/2011	DE102010019099A1 Ausgewählte Pflanzenextrakte zur Behandlung von Entzündungserkrankungen Selected plant extracts for the treatment of inflammatory diseases
11/03/2011	CA2800891A1 Use of kukoamine a and kukoamine b
11/03/2011	CA2800818A1 Cationic lipid
11/03/2011	CA2797772A1 Pyrazole compounds as jak inhibitors
11/03/2011	CA2795559A1 Crystalline peptide epoxyketone immunoproteasome inhibitor
11/03/2011	CA2795218A1 Polymorphs of a metabotropic glutamate receptor positive allosteric modulator
11/02/2011	EP2383336A1 Peptide capable of binding to immunoglobulin
11/02/2011	EP2382993A1 Combination of drugs with protein-binding prodrugs
11/02/2011	EP2382981A2 Use of Core 2 GlcNac-T inhibitors III for the treatment of inflammatory conditions
11/02/2011	EP2382980A2 Use of Core 2 GlcNac-T inhibitors III for treating vascular complications of diabetes
11/02/2011	EP2382979A2 Use of core 2 GlcNac-T inhibitors III for treating autoimmune diseases
11/02/2011	EP2382218A1 Delta-5-desaturase inhibitors
11/02/2011	EP2382212A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
11/02/2011	EP2382206A2 Compounds and methods for the treatment of pain and other diseases
11/02/2011	EP2382202A1 Dihydropyridone amides as p2x7 modulators
11/02/2011	EP2381957A2 Therapeutic modulation of vaginal epithelium boundary lubrication
11/02/2011	EP2381940A2 A new family of pain producing substances and methods to produce novel analgesic drugs
11/02/2011	EP2283008B1 Pyrrole derivatives, preparation of same and therapeutic application thereof
11/02/2011	EP2069354B1 Aza-benzofuranyl compounds and methods of use
11/02/2011	EP2051710B1 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
11/02/2011	EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
11/02/2011	EP1425389B1 Human antibodies specific for interleukin 15 (il-15)

1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 1272